Connecticut Attorney General William Tong announced four separate settlements with hearing aid companies: Lively Hearing Corporation, Widex USA, Inc., Hark Wellness, Inc., and Wonder Ear, Inc., who marketed their products as “FDA-approved” despite no such approval.
Hearing aids currently do not receive approval from the United States Food and Drug Administration (FDA) in the same manner as new drugs and some medical devices; however, hearing aid manufacturers register their products with the FDA.
Although Congress enacted legislation in 2017 permitting the FDA to create a category of over-the-counter (OTC) hearing aids, the FDA has not yet issued a final rule and no hearing aid suppliers should be marketing their products as OTC or “FDA-approved.”
Recent Posts
Where Audiology Comes Together: Join Us for AAA 2027 in St. Louis
Every year, the AAA Annual Convention brings the audiology community together to learn, connect, and move the profession forward. From April 7–10, 2027, that tradition…
CMS Releases Calendar Year 2027 Proposed Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (OPPS)
The Centers for Medicare and Medicaid Services (CMS) released the 2027 Medicare Physician Fee Schedule proposed rule late on July 14, 2026, reducing the PFS…
Vestibular Exercises May Improve Outcomes in Those with Intracerebral Hemorrhage
In a recent article study by Killedar and Kanase (2026), effects of vestibular stimulation exercises were analyzed in individuals with intracerebral hemorrhage. This study randomly…



